MedTrace Logo

Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome

NCT06496022 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-07-15

No results posted yet for this study

Summary

Assessing frailty syndrome in elderly patients in Almaty To study the features of the clinical course in the group of patients with a pre-frailty and in the group with frailty syndrome

Conditions

  • Frail Elderly Syndrome

Interventions

DIAGNOSTIC_TEST

Frail scale

FRAIL scale for determining frailty (tired most of the time in the last 4 weeks; the presence of more than 5 diseases; difficulty or inability when climbing stairs and walking around the block; weight loss of more than 5% of the previous weight in the last 6 months).

DIAGNOSTIC_TEST

Barthel scale

The Barthel scale is used to determine the degree of independence in daily life, the patient's household activity, the assessment of the quality of life and the necessary care.

DIAGNOSTIC_TEST

SARC-F

The SARC-F scale is used to identify muscle dysfunction (difficulty lifting things over 4.5 kg, walking around the room, difficulty climbing from a chair and up 10 steps, whether the respondent has fallen in the last year).

DIAGNOSTIC_TEST

FRAX

FRAX Scale (Kazakhstan platform) fracture and osteoporosis risk assessment on the website https://frax.shef.ac.uk/FRAX/tool.aspx?country=72

DIAGNOSTIC_TEST

Mini-Cog scale

The Mini-Cog scale defines cognitive impairment (cognitive impairment - when scoring less than 3 points based on remembering three words and evaluating the task of drawing a clock).

DIAGNOSTIC_TEST

dynamometry

carpal dynamometry (sarcopenia is exhibited at values below 26 units for men and below 16 units for women).

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-12-31
Completion
2025-03-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06496022 on ClinicalTrials.gov